Literature DB >> 2843088

Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam.

F Moosdeen1, J D Williams, S Yamabe.   

Abstract

The antibacterial activity, binding to penicillin-binding proteins, and morphological changes effected by YTR 830, a sulfone beta-lactamase inhibitor, were studied in comparison with those of other beta-lactamase inhibitors. YTR 830 had very poor antibacterial activity, bound to PBP 2 of gram-negative organisms, and at the MIC caused rapid lysis of spheroplasts formed.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2843088      PMCID： PMC172308          DOI： 10.1128/AAC.32.6.925

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Penicillin-binding proteins and cell shape in E. coli.

Authors:  B G Spratt; A B Pardee
Journal:  Nature       Date:  1975-04-10       Impact factor: 49.962

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

4.  In-vitro evaluation of sulbactam, a penicillanic acid sulphone with beta-lactamase inhibitory properties.

Authors:  D Greenwood; A Eley
Journal:  J Antimicrob Chemother       Date:  1982-08       Impact factor: 5.790

5.  Affinity of temocillin for Escherichia coli K-12 penicillin-binding proteins.

Authors:  R Labia; P Baron; J M Masson; G Hill; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

6.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

7.  Properties of the penicillin-binding proteins of Escherichia coli K12,.

Authors:  B G Spratt
Journal:  Eur J Biochem       Date:  1977-01

8.  In vitro activities of new beta-lactam antibiotics against Acinetobacter spp.

Authors:  I Garcia; V Fainstein; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

9.  Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.

Authors:  S C Aronoff; M R Jacobs; S Johenning; S Yamabe
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

10.  Affinities of penicillins and cephalosporins for the penicillin-binding proteins of Escherichia coli K-12 and their antibacterial activity.

Authors:  N A Curtis; D Orr; G W Ross; M G Boulton
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191
View more
  14 in total

1.  Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacy.

Authors:  Micheal Nottingham; Christopher R Bethel; Sundar Ram Reddy Pagadala; Emily Harry; Abishai Pinto; Zachary A Lemons; Sarah M Drawz; Focco van den Akker; Paul R Carey; Robert A Bonomo; John D Buynak
Journal:  Bioorg Med Chem Lett       Date:  2010-11-05       Impact factor: 2.823

Review 2.  Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.

Authors:  Carine Bebrone; Patricia Lassaux; Lionel Vercheval; Jean-Sébastien Sohier; Adrien Jehaes; Eric Sauvage; Moreno Galleni
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

3.  Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.

Authors:  M Pfaller; A Barry; P Fuchs; E Gerlach; D Hardy; J McLaughlin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-03       Impact factor: 3.267

4.  Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.

Authors:  K Bush; C Macalintal; B A Rasmussen; V J Lee; Y Yang
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

5.  Comparative activity of several antimicrobial agents against nosocomial Gram-negative rods isolated across Canada.

Authors:  S R Scriver; D E Low
Journal:  Can J Infect Dis       Date:  1995-03

6.  In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitors.

Authors:  William J Weiss; Peter J Petersen; Timothy M Murphy; Luanna Tardio; Youjun Yang; Patricia A Bradford; Aranapakam M Venkatesan; Takao Abe; Takeshi Isoda; Ado Mihira; Hideki Ushirogochi; Tsuyoshi Takasake; Steve Projan; John O'Connell; Tarek S Mansour
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

7.  In vitro activity of ceftazidime-avibactam combination in in vitro checkerboard assays.

Authors:  Johanna Berkhout; Maria J Melchers; Anita C van Mil; Wright W Nichols; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

8.  Sub-Inhibitory Concentration of Piperacillin-Tazobactam May be Related to Virulence Properties of Filamentous Escherichia coli.

Authors:  João Paulo Lopes de Andrade; Luiz de Macêdo Farias; João Fernando Gonçalves Ferreira; Oscar Bruna-Romero; Daniele da Glória de Souza; Maria Auxiliadora Roque de Carvalho; Kênia Valéria dos Santos
Journal:  Curr Microbiol       Date:  2015-09-12       Impact factor: 2.188

9.  Diverse potential of beta-lactamase inhibitors to induce class I enzymes.

Authors:  D A Weber; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

Review 10.  Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; R N Brogden
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.